Cargando…
Male breast cancer: a review
Male breast cancer (MBC) is rare, with the peak age of onset at 71 years. BRCA2 mutations are more frequent than BRCA1 with 20% of cases giving a family history. Risk factors for MBC are poorly understood and include working in high-ambient temperatures and exhaust fume exposure. MBC is associated w...
Autor principal: | Fentiman, IS |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223984/ https://www.ncbi.nlm.nih.gov/pubmed/22276005 http://dx.doi.org/10.3332/ecancer.2009.140 |
Ejemplares similares
-
Surgical options for male breast cancer
por: Fentiman, Ian S.
Publicado: (2018) -
Neoadjuvant treatment for male breast cancer
por: Fentiman, Ian Stuart
Publicado: (2023) -
The Role of Non-Steroidal Anti-Inflammatory Drugs in the Chemoprevention of Breast Cancer
por: Horn, Sarah L., et al.
Publicado: (2010) -
Multidisciplinary Atlas of Breast Surgery
por: Fentiman, Ian S
Publicado: (1998) -
The endocrine prevention of breast cancer.
por: Fentiman, I. S.
Publicado: (1989)